These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16181292)

  • 1. Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration.
    Larsson J; Gillies MC
    Clin Exp Ophthalmol; 2005 Oct; 33(5):544-5. PubMed ID: 16181292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
    Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
    Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration.
    Roth DB; Kulkarni KM; Feuer WJ
    Ophthalmic Surg Lasers Imaging; 2008; 39(1):12-6. PubMed ID: 18254345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial.
    Maberley D;
    Ophthalmology; 2009 Nov; 116(11):2149-57.e1. PubMed ID: 19748675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration.
    Ho TC
    Retina; 2006; 26(6):714; author reply 715. PubMed ID: 16829825
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cataract surgery after intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring RF
    Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound choroidal hypoperfusion after combined photodynamic therapy and intravitreal triamcinolone acetonide.
    Blaha GR; Wertz FD; Marx JL
    Ophthalmic Surg Lasers Imaging; 2008; 39(1):6-11. PubMed ID: 18254344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Amat P; Lugo FL
    J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color Doppler imaging of ocular blood flow after combined photodynamic therapy with intravitreal triamcinolone in age-related macular degeneration.
    Cekiç O; Bardak Y; Yeşildağ A
    Curr Eye Res; 2011 Feb; 36(2):149-53. PubMed ID: 21158585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.
    Danis RP; Ciulla TA; Pratt LM; Anliker W
    Retina; 2000; 20(3):244-50. PubMed ID: 10872928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration.
    Jonas JB; Libondi T; Golubkina L; Spandau UH; Schlichtenbrede F; Rensch F
    Acta Ophthalmol; 2010 Sep; 88(6):630-4. PubMed ID: 19432871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
    Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
    Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of cataracts following photodynamic therapy combined with intravitreous triamcinolone injection in cases of age-related macular degeneration.
    Iwami H; Kohno T; Yamamoto M; Kaida M; Miki N; Ataka S; Shiraki K
    Osaka City Med J; 2011 Dec; 57(2):49-57. PubMed ID: 22443078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
    Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
    Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
    Jonas JB; Akkoyun I; Budde WM; Kreissig I; Degenring RF
    Arch Ophthalmol; 2004 Feb; 122(2):218-22. PubMed ID: 14769599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.
    Jonas JB; Degenring RF; Kreissig I; Friedemann T; Akkoyun I
    Eye (Lond); 2005 Feb; 19(2):163-70. PubMed ID: 15218517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone acetonide for exudative age related macular degeneration.
    Jonas JB; Kreissig I; Hugger P; Sauder G; Panda-Jonas S; Degenring R
    Br J Ophthalmol; 2003 Apr; 87(4):462-8. PubMed ID: 12642311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract.
    Gillies MC; Kuzniarz M; Craig J; Ball M; Luo W; Simpson JM
    Ophthalmology; 2005 Jan; 112(1):139-43. PubMed ID: 15629834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.